The endocytotic c-type lectin receptor DEC-205 is highly expressed on immature dendritic cells. In previous studies, it was shown that antigen-targeting to DEC-205 is a useful tool for the induction of antigen-specific Foxp3+ regulatory T cells and thereby can prevent inflammatory processes. However, whether this approach is sufficient to mediate tolerance in mucosal tissues like the gut is unknown. In this study, we established a new mouse model in which the adoptive transfer of naive hemagglutinin (HA)-specific CD4+Foxp3− T cells into VILLIN-HA transgenic mice leads to severe colitis. To analyze if antigen-targeting to DEC-205 could protect against inflammation of the gut, VILLIN-HA transgenic mice were injected with an antibody–antigen complex consisting of the immunogenic HA110–120 peptide coupled to an α-DEC-205 antibody (DEC-HA) before adoptive T cell transfer. DEC-HAtreated mice showed significantly less signs of intestinal inflammation as was demonstrated by reduced loss of body weight and histopathology in the gut. Strikingly, abrogated intestinal inflammation was mediated via the conversion of naive HA-specific CD4+Foxp3− T cells into HA-specific CD4+Foxp3+ regulatory T cells. In this study, we provide evidence that antigen-targeting to DEC-205 can be utilized for the induction of tolerance in mucosal organs that are confronted with large numbers of exogenous antigens.
Hanauer SB , Sandborn WJ, Rutgeerts P, Fedorak RN, Lukas M, MacIntosh D, Panaccione R, Wolf D, Pollack P: Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn’s disease: the CLASSIC-I trial. Gastroenterology 130, 323–333; quiz 591 (2006)
Lichtenstein GR , Thomsen OØ, Schreiber S, Lawrance IC, Hanauer SB, Hanauer SB, Bloomfield R, Sandborn WJ: Precise 3 Study Investigators: Continuous therapy with certolizumab pegol maintains remission of patients with Crohn’s disease for up to 18 months. Clin Gastroenterol Hepatol 8, 600–609 (2010)
Shevach EM : Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636–645 (2009)
Mottet C , Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 170, 3939–3943 (2003)
Powrie F : T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 3, 171–174 (1995)
McMurchy AN , Bushell A, Levings MK, Wood KJ: Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 23, 304–313 (2011)
Steinman RM , Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K, Iyoda T, Ravetch J, Dhodapkar M, Inaba K, Nussenzweig M.: Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann N Y Acad Sci 987, 15–25 (2003)
Sun CM , Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 204, 1775–1785 (2007)
Coombes JL , Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204, 1757–1764 (2007)
Mahnke K , Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM: The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 151, 673–684 (2000)
Bonifaz L , Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM: Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J Exp Med 196, 1627–1638 (2002)
Mahnke K , Qian YJ, Knop J, Enk AH: Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101, 4862–4869 (2003)
Idoyaga J , Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, Rodriguez A, Clausen BE, Park CG, Trumpfheller C, Steinman RM: Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci U S A 108, 2384–2389 (2011)
Bruder D , Westendorf AM, Hansen W, Prettin S, Gruber AD, Qian Y, von Boehmer H, Mahnke K, Buer J: On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54, 3395–3401 (2005)
Stern JN , Keskin DB, Kato Z, Waldner H, Schallenberg S, Anderson A, von Boehmer H, Kretschmer K, Strominger JL: Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells. Proc Natl Acad Sci U S A 107, 17280–17285 (2010)
Fiocchi C : Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol-Gastrointest Liver Physiol 273, G769-G775 (1997)
Westendorf AM , Templin M, Geffers R, Deppenmeier S, Gruber AD, Probst-Kepper M, Hansen W, Liblau RS, Gunzer F, Bruder D, Buer J: CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut 54, 60–69 (2005)
Kirberg J , Baron A, Jakob S, Rolink A, Karjalainen K, von Boehmer H: Thymic Selection of CD8+ Single Positive Cells with a Class-Ii Major Histocompatibility Complex- Restricted Receptor. J Exp Med 180, 25–34 (1994)
Westendorf AM , Fleissner D, Deppenmeier S, Gruber AD, Bruder D, Hansen W, Liblau R, Buer J: Autoimmunemediated intestinal inflammation-impact and regulation of antigen-specific CD8+ T cells. Gastroenterology 131, 510–524 (2006)
Westendorf AM , Fleissner D, Groebe L, Jung S, Gruber AD, Hansen W, Buer J: CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells. Gut 58, 211–219 (2009)
Atkinson TP : Immune deficiency and autoimmunity. Curr Opin Rheumatol 24, 515–521 (2012)
Fontenot JD , Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4, 330–336 (2003)
Fontenot JD , Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329–341 (2005)
Hawiger D , Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194, 769–779 (2001)
Soares H , Waechter H, Glaichenhaus N, Mougneau E, Yagita H, Mizenina O, Dudziak D, Nussenzweig MC, Steinman RM: A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med 204, 1095–1106 (2007)
Bell SJ , Rigby R, English N, Mann SD, Knight SC, Kamm MA, Stagg AJ: Migration and maturation of human colonic dendritic cells. J Immunol 166, 4958–4967 (2001)
Sato A , Hashiguchi M, Toda E, Iwasaki A, Hachimura S, Kaminogawa S: CD11b+ Peyer’s patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J Immunol 171, 3684–3690 (2003)
Hawiger D , Masilamani RF, Bettelli E, Kuchroo VK, Nussenzweig MC: Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dentritic cells in vivo. Immunity 20, 695–705 (2004)
Kretschmer K , Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H: Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6, 1219–1227 (2005)
Lodes MJ , Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM: Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 113, 1296–1306 (2004)
Elson CO : Commensal bacteria as targets in Crohn’s disease. Gastroenterology 119, 254–257 (2000)
Cong Y , Brandwein SL, McCabe RP, Lazenby A, Birkenmeier EH, Sundberg JP, Elson CO: CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/He- JBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med 187, 855–864 (1998)
Shen C , Landers CJ, Derkowski C, Elson CO, Targan SR: Enhanced CBir1-specific innate and adaptive immune responses in Crohn’s disease. Inflamm Bowel Dis 14, 1641–1651 (2008)